Abstract
Biophotonic imaging technology offers a non-invasive solution for objectively and quantitatively staging diabetic retinopathy (DR) and detecting pre-DR before structural damage occurs. Integrating this technology into clinical practice enables more accurate staging, early risk management, and prediction of treatment outcomes, ultimately reducing DR-related structural damage. The platform featured a novel physics-based retinal oximetry algorithm, built on Saccadic-Phase Spatial Frequency Domain Imaging (SP-SFDI). This technology measured an oxygen saturation analogue (αSO2) in tissue with high resolution, detecting oxygenation changes <3% using two snapshots capturing phase shifts in spatially modulated light. Its first application, BioxyDR™, focused on measuring αSO2 in the superficial retinal vasculature for accurate DR staging and early detection. For clinical validation, the study included 63 DR patients, 60 diabetes mellitus (DM) patients without DR (DM no DR), and 18 controls (no DM, no known ocular diseases). Retinal venous αSO2 significantly differed (p = 0.007) between controls and patient groups, including proliferative (PDR) and non-proliferative DR (NPDR). 100% of controls and DR patients were correctly classified per standard-of-care (SOC) criteria. Among DM no DR patients, 8 were classified as pre-DR, and 7 (87%) developed DR within 18 months. Notably, all patients classified as not pre-DR (100%) remained DR-free. Initial studies across various ocular diseases showed distinct classifications based on venous and arterial αSO2. Taken together, these findings suggest that venous αSO2 measured with SP-SFDI may serve as a biomarker for DR progression, with higher αSO2 levels indicating greater disease severity. αSO2 also shows promise as a metric for staging pre-DR.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout













Similar content being viewed by others
Data availability
Correspondence and requests for materials should be addressed to Dr. Quan Dong Nguyen.
References
International Diabetes Federation. United States—IDF Diabetes Atlas data. https://diabetesatlas.org/data/en/country/211/us.html. Accessed August 20, 2023.
Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2004;45:617–24.
Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, et al. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998;39:1647–57.
Rishi P, Bhende P. Proliferative diabetic retinopathy. N Engl J Med. 2009;360:912.
Goldman D. Müller glial cell reprogramming and retina regeneration. Nat Rev Neurosci. 2014;15:431–42.
Simó R, Hernández C. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2014;25:23–33.
Hardarson SH, Stefánsson E, Bek T. Retinal oxygen saturation changes progressively over time in diabetic retinopathy. PLoS One. 2021;16:e0251607.
Veiby NC, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, et al. Venular oxygen saturation is increased in young patients with type 1 diabetes and mild nonproliferative diabetic retinopathy. Acta Ophthalmol. 2020;98:800–7.
Tayyari F, Khuu LA, Flanagan JG, Singer S, Brent MH, Hudson C. Retinal blood flow and retinal blood oxygen saturation in mild to moderate diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015;56:6796–800.
Hammer M, Vilser W, Riemer T, Mandecka A, Schweitzer D, Kühn U, et al. Diabetic patients with retinopathy show increased retinal venous oxygen saturation. Graefes Arch Clin Exp Ophthalmol. 2009;247:1025–30.
Ibrahim MA, Annam RE, Sepah YJ, Luu L, Bittencourt MG, Jang HS, et al. Assessment of oxygen saturation in retinal vessels of normal subjects and diabetic patients with and without retinopathy using Flow Oximetry System. Quant Imaging Med Surg. 2015;5:86–96.
Garg AK, Knight D, Lando L, Chao DL. Advances in retinal oximetry. Transl Vis Sci Technol. 2021;10:5 https://doi.org/10.1167/tvst.10.2.5.
Stefánsson E, Olafsdottir OB, Eliasdottir TS, Vehmeijer W, Einarsdottir AB, Bek T, et al. Retinal oximetry: metabolic imaging for diseases of the retina and brain. Prog Retin Eye Res. 2019;70:1–22. https://doi.org/10.1016/j.preteyeres.2019.04.001.
Liu X, Wang S, Liu Y, Liu LJ, Lv YY, Tang P, et al. Retinal oxygen saturation in Chinese adolescents. Acta Ophthalmol. 2017;95:e54–e61.
Fondi K, Wozniak PA, Howorka K, Bata AM, Aschinger GC, Popa-Cherecheanu A, et al. Retinal oxygen extraction in individuals with type 1 diabetes with no or mild diabetic retinopathy. Diabetologia. 2017;60:1534–40.
Torp TL, Kawasaki R, Wong TY, Peto T, Grauslund J. Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation. Br J Ophthalmol. 2018;102:383–7.
Guduru A, Martz TG, Waters A, Kshirsagar AV, Garg S. Oxygen saturation of retinal vessels in all stages of diabetic retinopathy and correlation to ultra-wide field fluorescein angiography. Invest Ophthalmol Vis Sci. 2016;57:5278–84.
Šínová I, Chrapek O, Mlčák P, Řehák J, Karhanová M, Šín M. Automatická retinální oxymetrie u pacientů s diabetickou retinopatií. Cesk Slov Oftalmol. 2016;72:182–6.
Jørgensen CM, Hardarson SH, Bek T. The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmol. 2014;92:34–9.
Hardarson SH, Stefánsson E. Retinal oxygen saturation is altered in diabetic retinopathy. Br J Ophthalmol. 2012;96:560–3.
Bresnick GH, Mukamel DB, Dickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy. Ophthalmology. 2000;107:19–24.
Arita R, Nakao S, Kita T, Kawahara S, Asato R, Yoshida S, et al. A key role for ROCK in TNF-α–mediated diabetic microvascular damage. Invest Ophthalmol Vis Sci. 2013;54:2373–83.
El-Menyar A, Al Thani H, Hussein A, Sadek A, Sharaf A, Al Suwaidi J. Diabetic retinopathy: a new predictor in patients on regular hemodialysis. Curr Med Res Opin. 2012;28:999–55.
Osaadon P, Fagan XJ, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye. 2014;28:510–20.
Arita R, Hata Y, Ishibashi T. ROCK as a therapeutic target of diabetic retinopathy. J Ophthalmol. 2010;2010:175163.
Stefánsson E. Diabetic macular edema. Saudi J Ophthalmol. 2009;23:143–8.
Mayo Clinic. Diabetic retinopathy—Diagnosis & treatment. https://www.mayoclinic.org/diseases-conditions/diabetic-retinopathy/diagnosis-treatment/drc-20371617. Published February 21, 2023.
Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Ranibizumab for diabetic macular edema. Ophthalmology. 2012;119:789–801.
Brown DM, Wykoff CC, Boyer D, Heier JS, Clark WL, Emanuelli A, et al. Evaluation of intravitreal aflibercept for the treatment of severe nonproliferative diabetic retinopathy. JAMA Ophthalmol. 2021;139:946–55.
Writing Committee for the DRCR Retina Network. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314:2137–46.
Thomas RL, Luzio SD, North RV, Banerjee S, Zekite A, Bunce C, et al. Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007–2015. BMJ Open. 2017;7:e015024.
Maturi RK, Glassman AR, Josić K, Baker CW, Gerstenblith AT, Jampol LM, et al. Four-year visual outcomes in a randomized trial of intravitreous aflibercept for prevention of vision-threatening complications of diabetic retinopathy (Protocol W). JAMA. 2023;329:409–20.
Hussein KA, Choksi K, Akeel S, Ahmad S, Megyerdi S, El-Sherbiny M, et al. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Exp Eye Res. 2014;125:79–88.
Wang H, Chhablani J, Freeman WR, Chan CK, Kozak I, Bartsch DU, et al. Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;153:861–7.
Jia Y, Morrison JC, Tokayer J, Tan O, Lombardi L, Baumann B, et al. Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express. 2012;3:3127–37.
Jia Y, Bailey ST, Hwang TS, McClintic SM, Gao SS, Pennesi ME, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci USA. 2015;112:E2395–402.
Chong SP, Merkle CW, Leahy C, Radhakrishnan H, Srinivasan VJ. Quantitative microvascular hemoglobin mapping using visible light spectroscopic optical coherence tomography. Biomed Opt Express. 2015;6:1429–50.
Liu X, Kang JU. Depth-resolved blood oxygen saturation assessment using spectroscopic common-path Fourier-domain OCT. IEEE Trans Biomed Eng. 2010;57:2572–5.
Chen S, Yi J, Zhang HF. Measuring oxygen saturation in retinal and choroidal circulations in rats using visible light OCT angiography. Biomed Opt Express. 2015;6:2840–53.
Soetikno BT, Yi J, Shah R, Liu W, Purta P, Zhang HF,et al.Inner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model. Sci Rep.2015;5:16752.
Yi J, Liu W, Chen S, Backman V, Zhang HF. Visible light optical coherence tomography measures retinal oxygen metabolic response to systemic oxygenation. Light Sci Appl. 2015;4:e334.
Yi J, Chen S, Backman V, Zhang HF. In vivo functional microangiography by visible-light optical coherence tomography. Biomed Opt Express. 2014;5:3603–12.
Rubinoff I, Kuranov RV, Wang Y, Ghassabi Z, Wollstein G, Tayebi B, et al. Clinical retinal oximetry with visible-light optical coherence tomography. Invest Ophthalmol Vis Sci. 2021;62:27.
Song W, Shao W, Yi W, Liu R, Desai M, Ness S, et al. Visible-light OCT angiography facilitates local microvascular oximetry in the human retina. Biomed Opt Express. 2020;11:4037–51.
Robles FE, Chowdhury S, Wax A. Assessing hemoglobin concentration using spectroscopic OCT for tissue diagnostics. Biomed Opt Express. 2010;1:310–7.
Rubinoff I, Kuranov RV, Fang R, Ghassabi Z, Wang Y, Beckmann L, et al. Adaptive spectroscopic visible-light optical coherence tomography for clinical retinal oximetry. Commun Med (Lond). 2023;3:57.
Shu X, Beckmann L, Wang Y, Rubinoff I, Lucy K, Ishikawa H, et al. Designing visible-light optical coherence tomography towards clinics. Quant Imaging Med Surg. 2019;9:769–81.
Waheed NK, Rosen RB, Jia Y, Munk MR, Huang D, Fawzi A, et al. Optical coherence tomography angiography in diabetic retinopathy. Prog Retin Eye Res. 2023;97:101206.
Grzybowski A, Brona P. Analysis and comparison of two artificial intelligence diabetic retinopathy screening algorithms in a pilot study: IDx-DR and Retinalyze. J Clin Med. 2021;10:2352.
Zotter S, Pircher M, Torzicky T, Bonesi M, Götzinger E, Leitgeb RA, et al. Visualization of microvasculature by dual-beam phase-resolved Doppler optical coherence tomography. Opt Express. 2011;19:1217–27.
Braaf B, Vermeer KA, Vienola KV, de Boer JF. Angiography of the retina and the choroid with phase-resolved OCT using interval-optimized backstitched B-scans. Opt Express. 2012;20:20516–28.
National Eye Institute. Diabetic retinopathy. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/diabetic-retinopathy. Published May 7, 2024.
Hickam JB, Sieker HO, Frayser R. Studies of retinal circulation and AV oxygen difference in man. Trans Am Clin Climatol Assoc. 1960;71:34–44.
Hickam JB, Frayser R, Ross JC. A study of retinal venous blood oxygen saturation in human subjects by photographic means. Circulation. 1963;27:375–85.
Pittman RN, Duling BR. A new method for the measurement of percent oxyhemoglobin. J Appl Physiol. 1975;38:315–20.
Delori FC. Noninvasive technique for oximetry of blood in retinal vessels. Appl Opt. 1988;27:1113–25.
Schweitzer D, Leistritz L, Hammer M, Scibor M, Bartsch U, Strobel J. Calibration-free measurement of the oxygen saturation in human retinal vessels. Proc SPIE. 1995;2393:210–8.
Schweitzer D, Hammer M, Kraft J, Thamm E, Königsdörffer E, Strobel J. In vivo measurement of the oxygen saturation of retinal vessels in healthy volunteers. IEEE Trans Biomed Eng. 1999;46:1454–65.
Geirsdottir A, Palsson O, Hardarson SH, Olafsdottir OB, Kristjansdottir JV, Stefánsson E. Retinal vessel oxygen saturation in healthy individuals. Invest Ophthalmol Vis Sci. 2012;53:5433–42.
Khoobehi B, Firn K, Thompson H, Reinoso M, Beach J. Retinal arterial and venous oxygen saturation is altered in diabetic patients. Invest Ophthalmol Vis Sci. 2013;54:7103–6.
Man RE, Sasongko MB, Kawasaki R, Noonan JE, Lo TC, Luu CD, et al. Oxygen saturation of retinal vasculature in healthy young adults. Invest Ophthalmol Vis Sci. 2014;55:1763–9.
Youssef PN, Sheibani N, Albert DM. Retinal light toxicity. Eye (Lond). 2011;25:1–14.
Hammer M, Roggan A, Schweitzer D, Müller G. Optical properties of ocular fundus tissues—an in vitro study using the double-integrating-sphere technique and inverse Monte Carlo simulation. Phys Med Biol. 1995;40:963–78.
Johnson WR, Wilson DW, Fink W, Humayun M, Bearman G. Snapshot hyperspectral imaging in ophthalmology. J Biomed Opt. 2007;12:014036.
Ramella-Roman JC, Mathews SA, Kandimalla H, Nabili A, Duncan DD, D’Anna SA, et al. Measurement of oxygen saturation in the retina with a spectroscopic sensitive multi aperture camera. Opt Express. 2008;16:6170–82.
Neumann J. Mikroskopische Untersuchungen zur laser-induzierten Blasenbildung und -dynamik an absorbierenden Mikropartikeln. Lübeck: Institute of Biomedical Optics; 2005.
Boucher F, Leblanc RM, Savage S, Beaulieu B. Depth-resolved chromophore analysis of bovine retina and pigment epithelium by photoacoustic spectroscopy. Appl Opt. 1986;25:515–20.
Van Blokland GJ, Van Norren D. Intensity and polarization of light scattered at small angles from the human fovea. Vision Res. 1986;26:485–94.
Gabel VP, Birngruber R, Hillenkamp F Visible and near infrared light absorption in pigment epithelium and choroid. In: Proc 23rd Consilium Ophthalmologicum, Kyoto. Excerpta Medica; 1978. p. 658-62.
Van Norren D, Tiemeijer LF. Spectral reflectance of the human eye. Vision Res. 1986;26:313–20.
Hammer M, Schweitzer D, Scibor M, Leistritz L, Hoffmann B. Comparison of different models for radiative transfer to the human ocular fundus using a new technique for spectral reflectance measurement. In: Proc 4th Int Meeting on Scanning Laser Ophthalmoscopy, Tomography and Microscopy; 1993.
Zhao Y, Qiu L, Sun Y, Huang C, Li T. Optimal hemoglobin extinction coefficient data set for near-infrared spectroscopy. Biomed Opt Express. 2017;8:5151–9.
Meng F, Alayash AI. Determination of extinction coefficients of human hemoglobin in various redox states. Anal Biochem. 2017;521:11–9.
Kim JG, Xia M, Liu H. Extinction coefficients of hemoglobin for near-infrared spectroscopy of tissue. IEEE Eng Med Biol Mag. 2005;24:118–21.
University of Arizona. Pulse oximeter laboratory. https://www.arizona.edu/.
Einarsdottir AB, Hardarson SH, Kristjansdottir JV, Bragason DT, Snaedal J, Stefánsson E. Retinal oximetry imaging in Alzheimer’s disease. J Alzheimers Dis. 2016;49:79–83.
Stefánsson E, Olafsdottir OB, Einarsdottir AB, Eliasdottir TS, Eysteinsson T, Vehmeijer W, et al. Retinal oximetry discovers novel biomarkers in retinal and brain diseases. Invest Ophthalmol Vis Sci. 2017;58:BIO227–BIO233.
Palsson O, Geirsdottir A, Hardarson SH, Olafsdottir OB, Kristjansdottir JV, Stefánsson E. Retinal oximetry images must be standardized: a methodological analysis. Invest Ophthalmol Vis Sci. 2012;53:1729–33.
Hirsch K, Cubbidge RP, Heitmar R. Dual wavelength retinal vessel oximetry: influence of fundus pigmentation. Eye. 2023;37:2246–51.
Bisignano KK, Smith JD, Harrison WW. Variations in retinal oxygen saturation in a diverse healthy population. Clin Optom. 2024;16:147–55.
Hammer M, Vilser W, Riemer T, Schweitzer D. Retinal vessel oximetry—calibration, compensation for vessel diameter and fundus pigmentation, and reproducibility. J Biomed Opt. 2008;13:054015.
Zilia. Non-invasive assessment of biomarkers in the eye. https://ziliahealth.com/. Published April 19, 2024.
Messier K. Comparison of optic nerve oxygen saturation in glaucomatous and normal patients with the Zilia ocular oximeter. Invest Ophthalmol Vis Sci. 2020;61:3921.
Reynolds L, Johnson C, Ishimaru A. Diffuse reflectance from a finite blood medium: applications to the modeling of fiber optic catheters. Appl Opt. 1976;15:2059–67.
Vogel A, Dlugos C, Nuffer R, Birngruber R. Die optischen Eigenschaften der menschlichen Sklera und deren Bedeutung für transsklerale Laseranwendungen. Fortschr Ophthalmol. 1991;88:754–63.
Delori FC, Pflibsen KP. Spectral reflectance of the human ocular fundus. Appl Opt. 1989;28:1061–77.
Schweitzer D, Königsdörffer E, Tröger G, Augsten R, Klein S, Roth H. Möglichkeiten und Grenzen der Fundusreflektometrie zum Nachweis von Veränderungen in einzelnen Schichten des Augenhintergrundes. Folia Ophthalmol. 1990;15:125–37.
Carroll J, Kay DB, Scoles D, Dubra A, Lombardo M. Adaptive optics retinal imaging—clinical opportunities and challenges. Curr Eye Res. 2013;38:709–21.
Kozak I. Retinal imaging using adaptive optics technology. Saudi J Ophthalmol. 2014;28:117–22.
Gibson DM. Estimates of the percentage of US adults with diabetes who could be screened for diabetic retinopathy in primary care settings. JAMA Ophthalmol. 2019;137:440–4.
Wilson FA, Stimpson JP, Wang Y. Inconsistencies exist in national estimates of eye care services utilization in the United States. J Ophthalmol. 2015;2015:408230.
Cuccia DJ, Bevilacqua F, Durkin AJ, Ayers FR, Tromberg BJ. Quantitation and mapping of tissue optical properties using modulated imaging. J Biomed Opt. 2009;14:024012.
Saager RB, Cuccia DJ, Durkin AJ. Determination of optical properties of turbid media spanning visible and near-infrared regimes via spatially modulated quantitative spectroscopy. J Biomed Opt. 2010;15:017012.
Konecky SD, Owen CM, Rice T, Valdés PA, Kolste K, Wilson BC, et al. Spatial frequency domain tomography of protoporphyrin IX fluorescence in preclinical glioma models. J Biomed Opt. 2012;17:056008.
Saager RB, Cuccia DJ, Saggese S, Kelly KM, Durkin AJ. An LED-based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging. Lasers Surg Med. 2013;45:207–15.
Mazhar A, Cuccia DJ, Gioux S, Durkin AJ, Frangioni JV, Tromberg BJ. Structured illumination enhances resolution and contrast in thick tissue fluorescence imaging. J Biomed Opt. 2010;15:010506.
Saager RB, Truong A, Cuccia DJ, Durkin AJ. Method for depth-resolved quantitation of optical properties in layered media using spatially modulated quantitative spectroscopy. J Biomed Opt. 2011;16:077002.
Gioux S, Choi HS, Frangioni JV. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging. 2010;9:237–55.
Mazhar A, Dell S, Cuccia DJ, Gioux S, Durkin AJ, Frangioni JV, et al. Wavelength optimization for rapid chromophore mapping using spatial frequency domain imaging. J Biomed Opt. 2010;15:061716.
Erickson TA, Mazhar A, Cuccia D, Durkin AJ, Tunnell JW. Lookup-table method for imaging optical properties with structured illumination beyond the diffusion theory regime. J Biomed Opt. 2010;15:036013.
Weber JR, Cuccia DJ, Tromberg BJ. Modulated imaging in layered media. Conf Proc IEEE Eng Med Biol Soc. 2006;2006:6674–6.
Basiri A, Nguyen TA, Ibrahim M, Nguyen QD, Ramella-Roman JC. Measuring the retina optical properties using a structured illumination imaging system. Proc SPIE. 2011;7885:78851X.
Nguyen JQ, Saager RB, Cuccia DJ, Kelly KM, Hsiang D, Durkin AJ. Motion correction in spatial frequency domain imaging: optical property determination in pigmented lesions. Proc SPIE. 2011;7883:78830P.
Vervandier J, Gioux S. Single snapshot imaging of optical properties. Biomed Opt Express. 2013;4:2938–44.
Ma C, Cheng D, Xu C, Wang Y. Design, simulation and experimental analysis of an anti-stray-light illumination system of fundus camera. Proc SPIE. 2014;9272:92720H.
Ye H, Gao Z, Qin Z, Wang Q. Near-infrared fundus camera based on polarization switch in stray light elimination. Chin Opt Lett. 2013;11:031702.
Basiri A A. functional medical imaging system for the measurement of oxygen saturation in the superficial retina vasculature. 2014. [Thesis].
Rahimi M, Leahy S, Blair NP, Shahidi M. Variability of retinal oxygen metrics in healthy and diabetic subjects. Transl Vis Sci Technol. 2021;10:20.
O’Connell RA, Anderson AJ, Hosking SL, Batcha AH, Bui BV. Test-retest reliability of retinal oxygen saturation measurement. Optom Vis Sci. 2014;91:608–14.
OHSU Casey Eye Institute. OCT tests for retina and macula. https://www.ohsu.edu/casey-eye-institute/oct-tests-retina-and-macula.
Böhm EW, Pfeiffer N, Wagner FM, Gericke A. Methods to measure blood flow and vascular reactivity in the retina. Front Med. 2023;9:1069449.
Acknowledgements
The authors would like to acknowledge the Bay Area Retina Associates (BARA) for facilitating this project. We also extend our gratitude to John Maroney for his dedicated commitment to the project.
Funding
This work was supported by the National Science Foundation (NSF) through the Small Business Innovation Research (SBIR) programme and was funded in part by Research to Prevent Blindness (Byers Eye Institute at Stanford) and NIH grant P30-EY026877 (Byers Eye Institute at Stanford).
Author information
Authors and Affiliations
Contributions
Conception/Design/Acquisition/Analysis/Interpretation (AB), Analysis/Interpretation (MSY), Acquisition/Interpretation (CL) Design/Acquisition (MS, JB), Design (HT), Interpretation (PA, TL, QDN), Drafting/Revision (all authors), Final Approval (all authors), Agreement of Accountability (all authors).
Corresponding author
Ethics declarations
Competing interests
AB, MSY, and MS are full-time employees of Bioxytech and hold equity in the company; they have also received payment. JB is a part-time employee of Bioxytech and has received payment. CL, TL, and QDN serve as consultants to Bioxytech and hold equity in the company. The remaining authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Basiri, A., Luo, C., Shokoohi-Yekta, M. et al. Assessing and monitoring abnormal retinal blood circulation for early detection of pre-structural damage and enhanced diabetic retinopathy staging using non-invasive, high-resolution biophotonic imaging technology. Eye (2025). https://doi.org/10.1038/s41433-025-04032-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-025-04032-5